Vitamin D
Cholecalciferol, Deficiency Correction and the Pilz 2011 Trial
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not Applicable (dietary supplement)
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about vitamin d in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Vitamin D follows the same deficiency-correction pattern as zinc. The most-cited trial is Pilz et al. (2011): 3,332 IU vitamin D daily for 12 months was associated with roughly 25% higher total testosterone in vitamin D-deficient men versus placebo, though these were overweight men in a concurrent weight-loss program, a confounder, and well-designed follow-up RCTs in non-deficient men have been largely null. The effect, where present, is a deficiency-correction effect and is weak in vitamin D-replete men. What makes this clinically relevant is how common deficiency is, roughly 40% of US adults, with higher rates in darker-skinned individuals and at northern latitudes, so correcting a genuine deficit can help in a large subgroup.
Helps the deficient, does little for the replete, and a lot of men are deficient.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Vitamin D functions as a secosteroid hormone; vitamin D receptors are expressed in testicular tissue including Leydig cells, and the activating enzymes are present in the male reproductive tract, suggesting a direct role in steroidogenesis. In deficiency, this signaling is impaired and testosterone tends to be lower; restoring adequate vitamin D status appears to improve it. As with zinc, repletion above sufficiency does not provide a further 'boost.'
Why the headline number misleads
The widely cited '+25% testosterone' from Pilz 2011 applies to vitamin D-deficient men over a full year, not to a replete man taking a pill for a few weeks. Supplement marketing strips the deficiency qualifier and the timeframe, implying a universal quarter-jump in testosterone. The honest read: if your level is low, correcting it can help; if it is already adequate, expect little. The high prevalence of deficiency is what makes vitamin D worth testing, not a magic effect of the vitamin itself.
What people get wrong
Often saidVitamin D raises testosterone 25% for everyone
ActuallyThe Pilz 2011 figure applies to deficient men over 12 months. In replete men, later RCTs show little to no testosterone effect.
Often saidYou can't overdo vitamin D
ActuallyExcessive supplementation causes hypercalcemia and other harms. Dosing should target correcting a measured deficiency, not maximizing intake.
Often saidSun exposure or a pill alone fixes everything
ActuallyVitamin D helps if you are deficient; it is one input among many and does not override sleep, body composition, or the HPG axis.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
The people taking it
Deficiency is most common in people with darker skin, limited sun exposure, higher latitudes, obesity (vitamin D sequestration in adipose tissue), and older age, overlapping substantially with groups that also tend to have lower testosterone, which is part of why testing-and-correcting is reasonable in these populations.
Set against the alternatives
Vitamin D sits in the deficiency-correction tier with zinc and magnesium, useful when a deficit exists, weak otherwise. Its broad appeal comes from how widespread deficiency is, not from a uniquely strong testosterone effect. It ranks below the major lifestyle levers.
At a glance
- Pilz 2011 dose
- 3,332 IU/day x 12 months
- Pilz 2011 effect
- ~+25% T in deficient men
- In replete men
- Weak effect
- US deficiency prevalence
- ~40% of adults
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Vitamin D. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Pilz et al. (Horm Metab Res)2011
3,332 IU/day for 12 months was associated with higher total (~25%), bioavailable (~12%), and free (~20%) testosterone versus placebo in vitamin D-deficient men, though subjects were overweight men in a concurrent weight-loss program, a confounder, and this remains the most-cited trial rather than a definitive one
Lerchbaum et al. (later RCTs in replete men)2017
Vitamin D supplementation did not significantly raise testosterone in men who were not deficient, reinforcing the deficiency-correction framing